Posttransplant nonfunction of canine islets in PVG rats deficient in complement component C6

Transplantation

Volumn 65, Issue 12, 1998, Pages 1549-1554

  Kronson, Jeffrey W ^a,b   Hering, Bernhard J ^a   Sutherland, David E R ^a   Tanioka, Yasuki ^a   Leone, John P ^a   Kirchhof, Nicole ^a   Dalmasso, Agustin P ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; COMPLEMENT COMPONENT C6; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; GENETIC COMPLEMENTATION; INFLAMMATORY CELL; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME; VASCULAR ENDOTHELIUM; XENOGRAFT;

ANIMALS; COMPLEMENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; DOGS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; RATS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032572289     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806270-00003     Document Type: Article

References (30)

1. Various. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977.
2. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DER. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990; 172: 291.
3. Auchincloss H. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
4. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
5. Dalmasso AP. The complement system in xenotransplantation. Immunopharmacology 1992; 24: 149.
6. Troppmann C, Gruessner AC, Papalois BE, Nakhleh RE, Gruessner RWG. Discordant xenoislets from a large animal donor undergo accelerated graft failure rather than hyperacute rejection: impact of immunosuppression, islet mass, and transplant site on early outcome. Surgery 1997; 121: 194.
7. Gray DWR, Song Z, Glover L, Welsh KI, Morris PJ. Tissue culture prevents hyperacute rejection of islet xenografts. Xenotransplantation 1995; 2: 157.
8. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402.
9. Dalmasso AP. Complement in the pathophysiology and diagnosis of human diseases. CRC Crit Rev Clin Lab Sci 1986; 24: 123.
10. Baldwin WM, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation: contributions to inflammation, injury, and rejection. Transplantation 1995; 59: 797.
11. Kilgore KS, Flory CM, Miller BF, Evans VM, Warren JS. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 1996; 149: 953.
12. Brauer RB, Baldwin WM, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151: 7240.
13. Kroshus TJ, Dalmasso AP, Leventhal JR, John R, Matas AJ, Bolman RM. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J Surg Res 1995; 59: 43.
14. McLean MH, Ryan WT, Hearn DJ. Comparison of the Beckman oxygen rate glucose method to a national reference and other methods. Am J Med Tech 1977; 43: 164.
15. Eloy R, Bouchet P, Clendinnen G, Daniel J, Grenier JF. New technique of total pancreatectomy without duodenectomy in the dog. Am J Surg 1980; 140: 409.
16. Warnock GL, Lakey JRT, Ao Z, Rajotte RV. Islet isolation from canine pancreas. In: Lanza RP, Chick WL, eds. Pancreatic islet transplantation: procurement of pancreatic islets, Vol. 1. Austin, TX: R.G. Landes Co., 1994: 81.
17. Pittman K, Thomas J, Thomas F. Reduction of primary nonfunction in discordant pancreas islet xenografts. Transplant Proc 1992; 24: 649.
18. Brayman KL, Morel P, Field MJ, et al. A comparison of mice and rats as recipients for canine islet xenografts. Transplant Proc 1992; 24: 651.
19. Deng S, Ketchum RJ, Levy MM, et al. Long-term culture or complement inhibition improves early islet function in dog to rat islet xenotransplantation. Transplant Proc 1996; 28: 805.
20. + macrophage and not a T lymphocyte. Transplantation 1995; 60: 594.
21. Corbett JA, McDaniel ML. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 1995; 181: 559.
22. Pittman K, Thomas F, McFadden T, Haisch C, Thomas J. Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy. Transplant Proc 1993; 25: 986.
23. Deng S, Ketchum RJ, Kucher T, et al. Adenoviral transfection of canine islet xenografts with immunosuppressive cytokine genes abrogates primary nonfunction and prolongs graft survival. Transplant Proc 1997; 29: 770.
24. Thomas F, Matthews C, Pittman K, Thomas J. 15-Deoxyspergualin produces inhibition of lymphokine-activated killer cell activity. Transplant Proc 1992; 24: 712
25. Schaapherder AFM, Wolvekamp MCJ, te Bulte MTJW, Bouwman E, Gooszen HG, Daha MR. Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms. Transplantation 1996; 62: 29.
26. Korbutt GS, Aspeslet LJ, Rajotte RV, et al. Natural human antibody-mediated destruction of porcine neonatal islet cell grafts. Xenotransplantation 1996; 3: 207.
27. Mirenda V, Le Mauff B, Cassard A, et al. Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation. Transplantation 1997; 63: 1452.
28. Beger C, Menger MD. RS-61443 prevents microvascular rejection of pancreatic islet xenografts. Transplantation 1997; 63: 577.
29. Kahan BD. Is there a rationale to combine cyclosporin and sirolimus? Nephrol Dial Transplant 1996; 11: 21.
30. Walter PK, Dickneite G, Schorlemmer HU, et al. Prolongation of graft survival in allogeneic islet transplantation by (-) 15-deoxyspergualin in the rat. Diabetologia 1987; 30: 38.